We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Download Mobile App




Events

ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.

CT Scan Study Shows Evidence of Persistent Lung Damage Long After COVID-19 Pneumonia

By MedImaging International staff writers
Posted on 01 Apr 2022
Print article
Image: Lung damage may persist long after COVID-19 pneumonia (Photo courtesy of Unsplash)
Image: Lung damage may persist long after COVID-19 pneumonia (Photo courtesy of Unsplash)

The COVID-19 pandemic, caused by the novel severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2), has considerably increased the demand for acute and post-acute healthcare worldwide. COVID-19’s short-term effects on the lungs, such as pneumonia, are well documented. Much less is known about the illness’ long-term effects on the lungs. CT has been an important imaging tool in the workup of patients suspected of having COVID-19. Now, a new study has found that some people recovering from COVID-19 pneumonia have CT evidence of damage to their lungs that persists a full year after the onset of symptoms. The study underscores radiology’s role in helping identify patients at risk for post-COVID-19 consequences and assisting in COVID-19 follow-up management.

As part of an observational study on the development of lung disease in patients with SARS-CoV-2 infection, researchers at Innsbruck Medical University (Innsbruck, Austria) looked at patterns and rates of improvement of chest CT abnormalities in patients one year after COVID-19 pneumonia. The researchers assessed lung abnormalities on chest CT in 91 participants, mean age 59 years, at several points over one year after the onset of COVID-19 symptoms.

At one year, CT abnormalities were present in 49, or 54%, of the 91 participants. Of these 49 participants, two (4%) had received outpatient treatment only, while 25 (51%) were treated on a general hospital ward and 22 (45%) had received intensive care unit (ICU) treatment. While CT abnormalities decreased in initial follow-ups, 63% of participants with abnormalities did not show any further improvement after six months. Age over 60 years, critical COVID-19 severity and male gender were associated with persistent CT abnormalities at one year. Evidence from the SARS-CoV-1 outbreak of 2002 to 2004 shows that lung abnormalities may remain detectable even after decades, but do not show any progression, according to the researchers. Recent studies, though, have shown a risk of progression of lung abnormalities such as the ones depicted on CT. The researchers intend to continue gathering data on patients with persistent CT abnormalities

“The observed chest CT abnormalities from our study are indicative of damaged lung tissue,” said study co-author Anna Luger, M.D., from the Department of Radiology at Innsbruck Medical University in Innsbruck, Austria. “However, it is currently unclear if they represent persistent scarring, and whether they regress over time or lead to pulmonary fibrosis.”

“In a recently published clinical study of our CovILD interdisciplinary working group, we were able to show that the severity of acute COVID-19, protracted systemic inflammation and the presence of residual chest CT abnormalities are strongly related to persistently impaired lung function and clinical symptoms,” said study co-author Christoph Schwabl, M.D., from Innsbruck Medical University.

“In the end, long-term follow-up, both clinical and radiological, is necessary to gather more information about the course and clinical role of persisting SARS-CoV-2 related chest CT abnormalities,” said study senior author Gerlig Widmann, M.D., chief thoracic radiologist at Innsbruck Medical University.

Related Links:
Innsbruck Medical University 

Gold Supplier
Premium Ultrasound Scanner
ARIETTA 850
New
Ceiling-Mounted Digital X-Ray System
DigitalDiagnost C50
New
Mobile Radiography System
NeuVision 550M (Plus)
New
Mega Pixel HF C-Arm
HMC-50D

Print article

Channels

MRI

view channel
Image: New scan measures tumor oxygen levels in real-time to help guide treatment (Photo courtesy of ICR)

Oxygen-Enhanced MRI Technology Allows Cancer Doctors to See Inside Tumors

Since the 1950s, researchers have been aware of the difficulty in effectively treating tumors deprived of oxygen, a problem that is further exacerbated when treating them with radiotherapy.... Read more

Ultrasound

view channel
Image: New focused ultrasound is effective for treating Parkinson’s, movement disorders (Photo courtesy of Pexels)

New Focused Ultrasound Treatment Proves Effective for Parkinson’s Disease Patients

Parkinson's disease is a neurological condition characterized by the loss of dopamine neurons within the brain. While medications such as levodopa can be effective in managing this condition, some patients... Read more

Nuclear Medicine

view channel
Image: Tracking radiation treatment in real time promises safer, more effective cancer therapy (Photo courtesy of Pexels)

Real-Time 3D Imaging Provides First-of-Its-Kind View of X-Rays Hitting Inside Body During Radiation Therapy

Radiation is used in treatment for hundreds of thousands of cancer patients each year, bombarding an area of the body with high energy waves and particles, usually X-rays. The radiation can kill cancer... Read more

General/Advanced Imaging

view channel
Image: Viz.ai is the first to receive FDA 510(k) clearance for an AI algorithm for abdominal aortic aneurysm (Photo courtesy of Pexels)

AI Algorithm Flags and Triages Suspected Abdominal Aortic Aneurysms from Chest CT Scans

An abdominal aortic aneurysm (AAA) denotes a bulge in the abdominal aorta, the chief artery that transfers blood from the heart to other parts of the body. If not detected and treated in time, AAA can... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2023 Globetech Media. All rights reserved.